Logan K. Wink, MD

Academic Affiliation

Assistant Professor

UC Department of Psychiatry and Behavioral Neuroscience

Phone 513-636-8375

Email logan.wink@cchmc.org

Autism spectrum disorders; Angelman syndrome.

Visit the Erickson/Wink Lab website.

Dr. Logan Wink is an assistant professor for the Division of Child Psychiatry at Cincinnati Children’s Hospital Medical Center within the UC Department of Psychiatry and Behavioral Neuroscience. Dr. Wink is a child and adolescent psychiatrist involved in clinical research and clinical care of individuals with developmental disabilities, including autism spectrum disorders and Angelman syndrome.

Her primary research focus is improving clinical care of individuals with developmental disabilities through better understanding the pathology of these disorders and improving pharmacologic treatment.

MD: Indiana University School of Medicine, Indianapolis, IN, 2007.

Residency: Psychiatry, Indiana University School of Medicine, Indianapolis, IN, 2011.

Fellowship: Child and Adolescent Psychiatry, Indiana University School of Medicine, Indianapolis, IN, 2012.

Fellowship: Autism and Developmental Disabilities, Indiana Division of Developmental Disability and Rehabilitative Services and the Indiana University School of Medicine, Department of Psychiatry, 2012.

Certification: Psychiatry Board Certification, 2011; Child and Adolescent Psychiatry Board Certification, 2012.

View PubMed Publications.

Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism. 2016 Apr 21;7:26.

Wink LK, Badran I, Pedapati EV, Sorensen R, Benton SC, Johnson MC, Wissel G, Erickson CA. Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability. J Child Adolesc Psychopharmacol. 2016 Nov;26(9):843-846.

Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, Hurwitz S, McDougle CJ, Swiezy NB, Erickson CA. A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Autism Spectrum Disorders. Molecular Autism. 2016 Jan 14;7:2.

Siegel M, Smith KA, Mazefsky C, Gabriels RL, Erickson C, Kapaln D, Morrow EM, Wink L, Santangelo SL. The autism inpatient collection: methods and preliminary sample description. Molecular Autism. 2015 Nov;6:61.

Wink LK, Pedapati EV, Horn PS, McDougle CJ, Erickson CA. Multiple Antipsychotic Use in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2015 Oct.

Wink LK, Fitzpatrick S, Shaffer RC, Melnyk S, Schaefer T, Mathieu-Frasier L, Ray B, Lahiri D, Erickson CA. The Neurobehavioral and Molecular Phenotype of Angelman Syndrome. Am J Med Genet A. 2015 Nov;167A(11):2623-8.

Adler BA, Wink LK, Early MC, Shaffer R, Minshawi N, McDougle CJ, Erickson CA. Drug-Refractory Aggression, Self-injurious Behavior, and Severe Tantrums in Autism Spectrum Disorders: A Chart Review Study. Autism. 2015 Jan;19(1):102-6.

Wink LK, O’Melia AM, Shaffer RC, Pedapati E, Friedmann K, Schaefer T, Erickson CA. Intranasal ketamine treatment in an adult with autism spectrum disorder. Journal of Clinical Psychiatry. 2014 Aug;75(8):835-36.

Vasa RA, Carroll LM, Nozzolillo AA, Mahajan R, Mazurek MO, Bennett AE, Wink LK, Bernal MP. A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders. J Autism Dev Disord. 2014 Dec;44(12):3215-29.

Wink LK, Early MC, Schaefer T, Bermingham R, Pottenger A, Horn P, McDougle CJ, Erickson CA. Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole. J Child Adolesc Psychopharmacol. 2014 Mar;24(2):78-82.

Investigator-Initiated clinical trial agreement. Principal Investigator. Roivant Sciences Ltd. May 2015-Apr 2017.

Rediscovery Research Award. Principal Investigator. Cures Within Reach. Nov 2015-Apr 2017.

Foundation Grant. Site Principal Investigator. Simons Foundation and Nancy Lurie Marks Foundation, Autism & Developmental Disorders Inpatient Research Collaborative. Apr 2014-Sep 2018.

Clinical Trial Protocol. Site Principal Investigator. Stemina Biomarker Discovery, Children’s Autism Metabolome Project (CAMP). Jun 2015-Jun 2017.